Why did the Federal Reserve renovation cost escalate?
How will the US-Japan tariff deal affect automakers?
What caused Tesla’s recent profit decline?
Why is UnitedHealth under federal investigation?
How did the Paramount-Skydance merger get FCC approval?
What impact will Trump’s AI action plan have?
Why are HydroTech hoses being recalled nationwide?
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives
investors.com/news/technology/alkermes-dives-orexin-agonist-narcolepsy-treatment
Alkermes stock skidded Monday on the back of mixed results for its experimental narcolepsy treatment, an orexin agonist.
The post Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives. appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-07-21 17:29:51.